Form D — Tango Therapeutics, Inc.
0001819133-25-000003 · filed 2025-10-28
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $14,999,995
- Total sold
- $14,999,995
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Tango Therapeutics, Inc.
- CIK
- 1819133
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 201 BROOKLINE AVENUE
BOSTON, MA 02215 - Phone
- (857) 320-4900
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Barbara Weber · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Daniella Beckman · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Adam Crystal · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Alexis Borisy · DirectorBoston, MA Find on LinkedIn ↗
-
Lesley Ann Calhoun · DirectorBoston, MA Find on LinkedIn ↗
-
Malte Peters · DirectorBoston, MA Find on LinkedIn ↗
-
Mace Rothenberg · DirectorBoston, MA Find on LinkedIn ↗
-
Kanishka Pothula · DirectorBoston, MA Find on LinkedIn ↗
-
John Ketchum · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.